Apo-Lamivudine-Zidovudine 300 mg

APO-Lamivudine-Zidovudine 300 MG tablets combine two antiretroviral medications used in HIV treatment. This oral medication is manufactured by Apotex Inc. in Canada.

APO-Lamivudine-Zidovudine 300 MG tablets are commonly used as part of antiretroviral therapy (ART) to manage HIV infection. This combination medication helps control the virus, reducing its ability to replicate in the body. It is typically prescribed to adults and children who require treatment for HIV. The primary use of APO-Lamivudine-Zidovudine is to suppress the HIV virus, helping to improve immune function and reduce the risk of HIV-related complications.

Common effects of APO-Lamivudine-Zidovudine 300 MG tablets may include nausea, headache, fatigue, and dizziness. Some individuals might experience changes in body fat distribution, such as increased waist size or loss of fat in the legs, arms, or face. It is important to discuss any persistent or severe side effects with a healthcare provider.

APO-Lamivudine-Zidovudine 300 MG tablets should be handled with care, especially if you have a history of liver or kidney problems. Regular monitoring of blood cell counts and liver function is recommended. This medication should be stored at room temperature, away from moisture and heat. Always follow the advice of a healthcare professional regarding the use of this medication.

APO-Lamivudine-Zidovudine 300 MG tablets may interact with other medications, including certain antibiotics, antifungals, and other antiretrovirals. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be limited, as it may exacerbate side effects.